Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Spector

Showing results (161-170 of 196) with videos related to

Pageof 20
Sort By:
Medical Care|August 11, 1991
A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infectionA W Wu, H R Rubin, W C Mathews, et al.
The Journal of Infectious Diseases|April 1, 1995
Absence of infectious retinitis after injection of human cytomegalovirus into rabbit eyesM Tatebayashi, J Neyts, G Besen, et al.
The Journal of Infectious Diseases|August 11, 1998
Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 TeamM Mirochnick, T Fenton, P Gagnier, et al.
Journal of Clinical Microbiology|August 1, 1987
Antibody to a synthetic oligopeptide in subjects at risk for human immunodeficiency virus infectionR S Smith, R B Naso, J Rosen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 1999
Treatment of human immunodeficiency virus 1-infected infants and children with the protease inhibitor nelfinavir mesylateP Krogstad, A Wiznia, K Luzuriaga, et al.
The Journal of Infectious Diseases|September 1, 1993
A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. AIDS Clinical Trials Group and Cytomegalovirus Cooperative Study GroupS A Spector, T Weingeist, R B Pollard, et al.
Annals of Neurology|December 10, 1997
Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center GroupR J Ellis, K Hsia, S A Spector, et al.
The New England Journal of Medicine|September 7, 1995
Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study GroupW L Drew, D Ives, J P Lalezari, et al.
The Journal of Infectious Diseases|February 1, 1991
The evolution of lymphadenopathy and hypergammaglobulinemia are evidence for early and sustained polyclonal B lymphocyte activation during human immunodeficiency virus infectionD L Jacobson, J A McCutchan, P L Spechko, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|February 1, 1995
Phase I/II evaluation of nevirapine alone and in combination with zidovudine for infection with human immunodeficiency virusS H Cheeseman, D Havlir, M M McLaughlin, et al.
Pageof 20

Showing results (161-170 of 196) with videos related to

Sort By:
Pageof 20
Medical Care|August 11, 1991
A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infectionA W Wu, H R Rubin, W C Mathews, et al.
The Journal of Infectious Diseases|April 1, 1995
Absence of infectious retinitis after injection of human cytomegalovirus into rabbit eyesM Tatebayashi, J Neyts, G Besen, et al.
The Journal of Infectious Diseases|August 11, 1998
Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 TeamM Mirochnick, T Fenton, P Gagnier, et al.
Journal of Clinical Microbiology|August 1, 1987
Antibody to a synthetic oligopeptide in subjects at risk for human immunodeficiency virus infectionR S Smith, R B Naso, J Rosen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 1999
Treatment of human immunodeficiency virus 1-infected infants and children with the protease inhibitor nelfinavir mesylateP Krogstad, A Wiznia, K Luzuriaga, et al.
The Journal of Infectious Diseases|September 1, 1993
A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. AIDS Clinical Trials Group and Cytomegalovirus Cooperative Study GroupS A Spector, T Weingeist, R B Pollard, et al.
Annals of Neurology|December 10, 1997
Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center GroupR J Ellis, K Hsia, S A Spector, et al.
The New England Journal of Medicine|September 7, 1995
Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study GroupW L Drew, D Ives, J P Lalezari, et al.
The Journal of Infectious Diseases|February 1, 1991
The evolution of lymphadenopathy and hypergammaglobulinemia are evidence for early and sustained polyclonal B lymphocyte activation during human immunodeficiency virus infectionD L Jacobson, J A McCutchan, P L Spechko, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|February 1, 1995
Phase I/II evaluation of nevirapine alone and in combination with zidovudine for infection with human immunodeficiency virusS H Cheeseman, D Havlir, M M McLaughlin, et al.
Pageof 20